SFX by Ex Libris Inc.

Title:	Up-regulation of vaults may be necessary but not sufficient for multidrug resistance
Source:	International Journal of Cancer [0020-7136] Siva, Amara yr:2001

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Stein, U. "YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene." Oncogene 24.22 (2005): 3606-18.
description	2.	Rosen, H.. "The rise and rise of drug delivery." Nature reviews. Drug discovery 4.5 (2005): 381-385.
description	3.	Colombo, P. "Novel Platforms for Oral Drug Delivery." Pharmaceutical research 26.3 (2009): 601-611.
description	4.	Nagayama, S. "Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells." Journal of the National Cancer Institute 91.19 (1999): 1647-1653.
description	5.	Matschke, C. "Sustained-release injectables formed in situ and their potential use for veterinary products." Journal of controlled release 85.1-3 (2003): 1-15.
description	6.	Hurt, Richard D. "Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial." JAMA 280.13 (1998): 1173-81.
description	7.	Johnson-Leger, C. "Protein therapeutics - lessons learned and a view of the future." Expert Opinion on Biological Therapy 6.1 (2006): 1-7.
description	8.	Martin, Charles R. "The emerging field of nanotube biotechnology." Nature reviews. Drug discovery 2.1 (2003): 29-37.
description	9.	Lowman, J. "Synthesis, Characterization and In Vivo Efficacy of PEGylated Insulin for Oral Delivery with Complexation Hydrogels." Pharmaceutical Research 26.3 (2009): 727-739.
description	10.	Lin, Y. "Advances toward bioapplications of carbon nanotubes." Journal of materials chemistry 14.4 (2004): 527-541.
description	11.	Whitehead, K.. "Safe and effective permeation enhancers for oral drug delivery." Pharmaceutical research 25.8 (2008): 1782-1788.
description	12.	Verhoeven, E. "Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusion." European journal of pharmaceutics and biopharmaceutics 69.1 (2008): 312-319.
description	13.	Kranz, R. "A novel in situ forming drug delivery system for controlled parenteral drug delivery." International Journal of Pharmaceutics 332.1-2 (2007): 107-14.
description	14.	Berkland, Laura J R. "Nanotechnology in vaccine delivery." Advanced Drug Delivery Reviews 60.8 (2008): 915-28.
description	15.	Li, Matthew L. "The use of hypromellose in oral drug delivery." Journal of Pharmacy and Pharmacology 57.5 (2005): 533-46.
description	16.	Martin, Charles R R. "Smart nanotubes for biotechnology." Current pharmaceutical biotechnology 6.1: 35-47.
description	17.	LACERDA, L. "Carbon nanotubes as nanomedicines: From toxicology to pharmacology." Advanced Drug Delivery Reviews 58.14 (2006): 1460-1470.
description	18.	Choi, Y. "Biosensing with conically shaped nanopores and nanotubes." Physical chemistry chemical physics 8.43 (2006): 4976-4988.
description	19.	Cross, Graham H. "The metrics of surface adsorbed small molecules on the Young's fringe dual-slab waveguide interferometer." Journal of physics. D, applied physics 37.1 (2004): 74-80.
description	20.	Punfa, W. "Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells." Acta pharmacologica Sinica 33.6 (2012): 823-31.